Back to Journals » Pharmacogenomics and Personalized Medicine
Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
An international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
We are currently seeking expressions of interest for an Associate Editor position and for Editorial Board members for this journal.
Please send your CV and a one-page vision statement detailing your overall objectives for the journal to Emi Kirilova - [email protected]. Please be sure to indicate whether you are interested in the Associate Editor role or a position on the Editorial Board in your application.
Articles:
- View all (644)
- Volume 17, 2024 (23)
- Volume 16, 2023 (97)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Latest articles:
- 5 records -
Preliminary Study on Clinical Characteristics and Pathogenesis of IQSEC2 Mutations Patients
Ren Y, Luo X, Tong H, Wang S, Yan J, Lin L, Chen Y
Pharmacogenomics and Personalized Medicine 2024, 17:289-318
Published Date: 29 May 2024
The Correlation of Centromere Protein Q with Diagnosis and Prognosis in Hepatocellular Carcinoma
He K, Xie MY, Gao XJ, Wang H, Li JD
Pharmacogenomics and Personalized Medicine 2024, 17:271-288
Published Date: 27 May 2024
An Aging-Related lncRNA Signature Establishing for Breast Cancer Prognosis and Immunotherapy Responsiveness Prediction
Zhou Y, Yang Z, Zeng H
Pharmacogenomics and Personalized Medicine 2024, 17:251-270
Published Date: 23 May 2024
16S rRNA Gene Sequencing of Gut Microbiota in Rheumatoid Arthritis Treated with 99Tc-MDP
Huang Z, Chen C, Tan L, Ling Y, Ma W, Zhang J
Pharmacogenomics and Personalized Medicine 2024, 17:237-249
Published Date: 23 May 2024
Evaluation of CYP2C19 Genetic Variant and Its Lack of Association with Valproic Acid Plasma Concentrations Among Zhuang and Han Schizophrenia Patients in Guangxi
Teng JM, Qin S, Lu D, Gu Y, Tang SJ, Yan Q, Yao J, Zhang C
Pharmacogenomics and Personalized Medicine 2024, 17:225-236
Published Date: 14 May 2024